-
Fund Dashboard
- Holdings
HARTFORD HEALTHCARE HLS FUND
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 14.18 mm | 18.37 k shares | 12.05 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 11.11 mm | 21.96 k shares | 9.45 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 5.21 mm | 9.99 k shares | 4.43 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 5.18 mm | 52.06 k shares | 4.40 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 5.03 mm | 56.28 k shares | 4.27 | Common equity | Long | USA |
DHR Danaher Corporation | 3.68 mm | 16.03 k shares | 3.13 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 3.49 mm | 6.71 k shares | 2.97 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 3.10 mm | 7.70 k shares | 2.64 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 2.78 mm | 37.53 k shares | 2.36 | Common equity | Long | USA |
COR Cencora | 2.51 mm | 11.19 k shares | 2.14 | Common equity | Long | USA |
ABBV AbbVie Inc. | 2.43 mm | 13.68 k shares | 2.07 | Common equity | Long | USA |
JNJ Johnson & Johnson | 2.36 mm | 16.32 k shares | 2.01 | Common equity | Long | USA |
HCA HCA Healthcare, Inc. | 2.35 mm | 7.83 k shares | 2.00 | Common equity | Long | USA |
AstraZeneca PLC
|
2.18 mm | 33.31 k shares | 1.86 | Common equity | Long | UK |
A Agilent Technologies, Inc. | 1.57 mm | 11.67 k shares | 1.33 | Common equity | Long | USA |
CNC Centene Corporation | 1.55 mm | 25.65 k shares | 1.32 | Common equity | Long | USA |
Argenx SE
|
1.47 mm | 2.39 k shares | 1.25 | Common equity | Long | Netherlands |
Novo Nordisk A/S
|
1.45 mm | 16.80 k shares | 1.23 | Common equity | Long | Denmark |
ICON PLC
|
1.45 mm | 6.91 k shares | 1.23 | Common equity | Long | Ireland |
ABT Abbott Laboratories | 1.44 mm | 12.77 k shares | 1.23 | Common equity | Long | USA |
GKOS Glaukos Corporation | 1.21 mm | 8.05 k shares | 1.03 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 1.18 mm | 1.66 k shares | 1.01 | Common equity | Long | USA |
HUM Humana Inc. | 1.18 mm | 4.65 k shares | 1.00 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 1.18 mm | 20.91 k shares | 1.00 | Common equity | Long | USA |
UCB SA
|
1.12 mm | 5.60 k shares | 0.95 | Common equity | Long | Belgium |
MOH Molina Healthcare, Inc. | 1.08 mm | 3.71 k shares | 0.92 | Common equity | Long | USA |
PODD Insulet Corporation | 1.07 mm | 4.09 k shares | 0.91 | Common equity | Long | USA |
ACHC Acadia Healthcare Company, Inc. | 1.05 mm | 26.36 k shares | 0.89 | Common equity | Long | USA |
LH Laboratory Corporation of America Holdings | 1.02 mm | 4.43 k shares | 0.86 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 1.01 mm | 2.87 k shares | 0.86 | Common equity | Long | USA |
Daiichi Sankyo Co Ltd
|
943.81 k | 34.49 k shares | 0.80 | Common equity | Long | Japan |
EHC Encompass Health Corporation | 904.66 k | 9.80 k shares | 0.77 | Common equity | Long | USA |
Astellas Pharma Inc
|
866.05 k | 89.19 k shares | 0.74 | Common equity | Long | Japan |
VRNA Verona Pharma plc | 848.37 k | 18.27 k shares | 0.72 | Common equity | Long | UK |
GSK PLC
|
845.10 k | 50.10 k shares | 0.72 | Common equity | Long | UK |
LFST LifeStance Health Group, Inc. | 796.25 k | 108.04 k shares | 0.68 | Common equity | Long | USA |
ADUS Addus HomeCare Corporation | 789.33 k | 6.30 k shares | 0.67 | Common equity | Long | USA |
SYK Stryker Corporation | 706.78 k | 1.96 k shares | 0.60 | Common equity | Long | USA |
Galderma Group AG
|
701.17 k | 6.32 k shares | 0.60 | Common equity | Long | Switzerland |
RVMD Revolution Medicines, Inc. | 692.54 k | 15.83 k shares | 0.59 | Common equity | Long | USA |
ELV Elevance Health Inc. | 676.93 k | 1.84 k shares | 0.58 | Common equity | Long | USA |
QIAGEN NV
|
669.64 k | 15.04 k shares | 0.57 | Common equity | Long | Netherlands |
SRPT Sarepta Therapeutics, Inc. | 642.48 k | 5.28 k shares | 0.55 | Common equity | Long | USA |
ELAN Elanco Animal Health Incorporated | 635.31 k | 52.46 k shares | 0.54 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 630.63 k | 2.68 k shares | 0.54 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 625.57 k | 4.54 k shares | 0.53 | Common equity | Long | Denmark |
OPCH Option Care Health, Inc. | 624.50 k | 26.92 k shares | 0.53 | Common equity | Long | USA |
AMGN Amgen Inc. | 591.13 k | 2.27 k shares | 0.50 | Common equity | Long | USA |
WAT Waters Corporation | 590.23 k | 1.59 k shares | 0.50 | Common equity | Long | USA |
NTRA Natera, Inc. | 589.51 k | 3.72 k shares | 0.50 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 574.80 k | 19.77 k shares | 0.49 | Common equity | Long | USA |
ARDT Ardent Health Partners, LLC | 571.72 k | 33.47 k shares | 0.49 | Common equity | Long | USA |
ALHC Alignment Healthcare, Inc. | 571.54 k | 50.80 k shares | 0.49 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 560.49 k | 10.96 k shares | 0.48 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 554.43 k | 2.66 k shares | 0.47 | Common equity | Long | USA |
DiaSorin SpA
|
499.63 k | 4.84 k shares | 0.42 | Common equity | Long | Italy |
SRRK Scholar Rock Holding Corporation | 484.45 k | 11.21 k shares | 0.41 | Common equity | Long | USA |
PRVA Privia Health Group, Inc. | 482.79 k | 24.70 k shares | 0.41 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 458.09 k | 5.60 k shares | 0.39 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 456.96 k | 10.86 k shares | 0.39 | Common equity | Long | USA |
Eisai Co Ltd
|
444.09 k | 16.31 k shares | 0.38 | Common equity | Long | Japan |
CYTK Cytokinetics, Incorporated | 443.30 k | 9.42 k shares | 0.38 | Common equity | Long | USA |
SGRY Surgery Partners, Inc. | 437.65 k | 20.67 k shares | 0.37 | Common equity | Long | USA |
Merus NV
|
436.27 k | 10.38 k shares | 0.37 | Common equity | Long | Netherlands |
TECH Bio-Techne Corporation | 435.13 k | 6.04 k shares | 0.37 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 403.10 k | 6.36 k shares | 0.34 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 394.88 k | 14.19 k shares | 0.34 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 393.80 k | 4.51 k shares | 0.33 | Common equity | Long | USA |
EVH Evolent Health, Inc. | 392.96 k | 34.93 k shares | 0.33 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 387.37 k | 9.88 k shares | 0.33 | Common equity | Long | Canada |
GPCR Structure Therapeutics Inc. | 387.08 k | 14.27 k shares | 0.33 | Common equity | Long | Cayman Islands |
CLDX Celldex Therapeutics, Inc. | 386.53 k | 15.30 k shares | 0.33 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 385.54 k | 8.58 k shares | 0.33 | Common equity | Long | USA |
HOLX Hologic, Inc. | 378.40 k | 5.25 k shares | 0.32 | Common equity | Long | USA |
GERN Geron Corporation | 368.16 k | 104.00 k shares | 0.31 | Common equity | Long | USA |
BIIB Biogen Inc. | 364.26 k | 2.38 k shares | 0.31 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 364.16 k | 4.65 k shares | 0.31 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 359.45 k | 19.08 k shares | 0.31 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 350.11 k | 7.76 k shares | 0.30 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 340.18 k | 8.46 k shares | 0.29 | Common equity | Long | USA |
Zai Lab Ltd
|
330.91 k | 12.64 k shares | 0.28 | Common equity | Long | Cayman Islands |
MLTX MoonLake Immunotherapeutics | 330.75 k | 6.11 k shares | 0.28 | Common equity | Long | Cayman Islands |
SYRE Spyre Therapeutics, Inc. | 329.09 k | 14.14 k shares | 0.28 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 320.41 k | 10.04 k shares | 0.27 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 303.40 k | 24.14 k shares | 0.26 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 291.25 k | 9.87 k shares | 0.25 | Common equity | Long | UK |
PACS PACS Group, Inc. | 281.73 k | 21.49 k shares | 0.24 | Common equity | Long | USA |
Tecan Group AG
|
269.00 k | 1.21 k shares | 0.23 | Common equity | Long | Switzerland |
FOLD Amicus Therapeutics, Inc. | 267.87 k | 28.44 k shares | 0.23 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 265.05 k | 5.85 k shares | 0.23 | Common equity | Long | USA |
Immatics NV
|
248.85 k | 35.00 k shares | 0.21 | Common equity | Long | Netherlands |
SVRA Savara Inc. | 244.65 k | 79.69 k shares | 0.21 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 243.99 k | 6.98 k shares | 0.21 | Common equity | Long | USA |
Genus PLC
|
237.01 k | 12.23 k shares | 0.20 | Common equity | Long | UK |
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
|
236.21 k | 11.30 k shares | 0.20 | Common equity | Long | China |
AGL agilon health, inc. | 194.55 k | 102.40 k shares | 0.17 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 194.51 k | 3.63 k shares | 0.17 | Common equity | Long | USA |
CONTRA ABIOMED INC | 902.70 | 885.00 shares | 0.00 | Equity derivative | N/A | USA |